A Phase II Study of Dual Immune Checkpoint Blockade (ICB) Plus Androgen Receptor (AR) Blockade to Enhance Thymic T-cell Production and Immunotherapy Response in Metastatic Breast Cancer (MBC).
Cancer Research（2022）
Key words
Immune Checkpoint Blockade,Biomarkers for Immunotherapy,Metastatic Breast Cancer,Combination Therapies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined